Retrospecto do controle da tuberculose no brasil Reportar como inadecuado

Retrospecto do controle da tuberculose no brasil - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Germano Gerhardt ; Gilmário M Teixeira ; Maria José Procópio ;Revista de Saúde Pública 2007, 41 1

Autor: Miguel Aiub Hijjar



Revista de Saúde Pública ISSN: 0034-8910 Universidade de São Paulo Brasil Aiub Hijjar, Miguel; Gerhardt, Germano; Teixeira, Gilmário M; Procópio, Maria José Retrospecto do controle da tuberculose no Brasil Revista de Saúde Pública, vol.
41, núm.
1, septiembre, 2007, pp.
50-58 Universidade de São Paulo São Paulo, Brasil Available in: How to cite Complete issue More information about this article Journals homepage in Scientific Information System Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Non-profit academic project, developed under the open access initiative Rev Saúde Pública 2007;41(Supl.
1) Miguel Aiub HijjarI Germano GerhardtII Gilmário M TeixeiraI Retrospect of tuberculosis control in Brazil Maria José ProcópioI ABSTRACT The aim of the study was to look back on the course of action involving measures of tuberculosis control in Brazil since the end of the 19th century, covering the history of social struggles and pointing out institutions and people that have dedicated themselves to looking for solutions to these issues.
The Brazilian response to tuberculosis started in society with the Ligas Contra a Tuberculose (Leagues Against Tuberculosis), promoting scientific advances, such as the BCG vaccination, which begun in 1927.
From the public power, the Inspetoria de Profilaxia da TB (TB Prophylaxis Inspection Service – 1920), the Serviço Nacional de Tuberculose (National Service of Tuberculosis – 1940), and the Campanha Nacional Contra a Tuberculose (National Campaign Against Tuberculosis – 1946), coordinated national policies such as chemotherapy, beginning with the discovery of streptomycin in 1944.
The emergence of bacterial resistance led to the development of several therapeutic schemes.
The Scheme 1 (rifampycin, hydrazide and pyrazinamid), which was the main one in 1979 and is still used nowadays, had a great ep...

Documentos relacionados